@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-Keio_Univ-KO003426 a mbo:MassSpectrum ;
    dcterms:creator "Kakazu Y, Horai H, Institute for Advanced Biosciences, Keio Univ." ;
    dcterms:date "2016-01-19 (Created 2007-07-07, modified 2012-05-21)"^^xsd:date ;
    dcterms:identifier "MSBNK-Keio_Univ-KO003426" ;
    dcterms:license <https://creativecommons.org/licenses/by/4.0/> ;
    dcterms:rights " under CC BY-NC-SA" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "API3000, Applied Biosystems" ;
            mbo:collision_energy "50 V" ;
            mbo:instrument_type "LC-ESI-QQ" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            rdfs:label "Methotrexate" ;
            mbo:ch_compound_class "N/A" ;
            mbo:ch_exact_mass 4.541713e+02 ;
            rdfs:seeAlso cas:59-05-2,
                <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CIDSID:5042> ;
            schema:inChI "InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)" ;
            schema:inChIKey inchikey:FBOZXECLQNJBKD-UHFFFAOYSA-N ;
            schema:molecularFormula "C20H22N8O5" ;
            schema:name "Methotrexate" ;
            schema:smiles "OC(=O)CCC(C(O)=O)NC(=O)c(c3)ccc(c3)N(C)Cc(c2)nc(c(N)1)c(n2)nc(N)n1" ] ;
    mbo:has_peak [ mbo:intensity 2.9703e+04 ;
            mbo:mz 7.28e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 4.9505e+04 ;
            mbo:mz 2.451e+02 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 6 ],
        [ mbo:intensity 2.9703e+04 ;
            mbo:mz 2.641e+02 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 3.9604e+04 ;
            mbo:mz 9.52e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 2.9703e+04 ;
            mbo:mz 1.051e+02 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 3 ],
        [ mbo:intensity 8.866346e+06 ;
            mbo:mz 1.123e+02 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 1.237625e+05 ;
            mbo:mz 1.169e+02 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 14 ],
        [ mbo:intensity 2.47525e+05 ;
            mbo:mz 1.34e+02 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 28 ],
        [ mbo:intensity 4.702975e+05 ;
            mbo:mz 1.752e+02 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 53 ],
        [ mbo:intensity 3.9604e+04 ;
            mbo:mz 1.762e+02 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 4 ],
        [ mbo:intensity 2.47525e+04 ;
            mbo:mz 2.442e+02 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 3 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 4.55e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 11 ;
    mbo:pk_splash "splash10-03di-0900000000-8dd46025bf221c1ec641" ;
    rdfs:comment "KEIO_ID M048" ;
    skos:definition "Methotrexate; LC-ESI-QQ; MS2; CE:50 V; [M+H]+" .

